About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

An EORTC Study Updating the QLQ-BR23 to BR45

NCT04270123·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Leeds

With

The Leeds Teaching Hospitals NHS Trust
European Organisation for Research and Treatment of Cancer - EORTC

Age

18–any

Sex

FEMALE

Healthy volunteers

Accepted

You may be eligible if

Adult females aged 18 years or over
Histologically confirmed diagnosis of breast cancer (any type) with no previous primary or recurrent tumour
Receiving or have previously received curative or palliative treatment.
Able to understand/speak English and complete the questionaires
Have the capacity/mental fitness to give written informed consent and complete the questionnaires.

You may not be if

Male gender or transgender
Inability to understand/speak English and complete the questionnaire
Patients with any psychiatric condition or cognitive impairment, as determined by the treating physician, that would hamper participation.

The record

StatusCompleted

PhaseNo phase

Taking part38

StartedNov 2020

UpdatedDec 1, 2023

Conditions

Cancer Breast Cancer

Where1

Leeds Teaching Hospitals NHS Trust
Leeds, West Yorkshire, United Kingdom

Clareo Health | An EORTC Study Updating the QLQ-BR23 to BR45